Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HIVE | SBET |
|---|---|---|
| Price | $2.75 | $8.95 |
| Change today | ▼ 5.17% | ▼ 5.79% |
| Market cap | $754.26M | $1.94B |
| Return, 3 months | -18.2% | +68.2% |
| Return, year to date | +6.6% | +0.1% |
| Return, 1 year | -58.0% | -49.1% |
| P/E (TTM) | -2.0 | -2.0 |
| P/B | 1.8 | 1.4 |
| P/E percentile vs own 5y | 60th | 11th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +73.5% | +1,553.9% |
| Net profit growth (YoY) | -508.1% | -281.2% |
| Gross margin | -25.9% | 97.0% |
| Operating margin | -76.8% | -18.4% |
| Net margin | -98.5% | -3,406.3% |
| Return on equity | -66.4% | -183.6% |
| Analyst target vs. price | +148.4% | +97.4% |
| Analyst buy share | 83% | 100% |
| RSI (14) | 39 | 50 |
| 30-day volatility | 72.7% | 80.6% |
| Max drawdown, 1 year | -74.9% | -76.3% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
